Các bài viết có thể truy cập công khai - Huihui YeTìm hiểu thêm
Không có ở bất kỳ nơi nào: 1
Stromal anti-apoptotic androgen receptor target gene c-FLIP in prostate cancer
H Ye, Y Li, J Melamed, P Pearce, J Wei, L Chiriboga, Z Wang, I Osman, ...
The Journal of urology 181 (2), 872-877, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Có tại một số nơi: 49
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
Các cơ quan ủy nhiệm: US National Institutes of Health
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II …
ME Taplin, B Montgomery, CJ Logothetis, GJ Bubley, JP Richie, BL Dalkin, ...
Journal of clinical oncology 32 (33), 3705-3715, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors
EJ Chen, AG Sowalsky, S Gao, C Cai, O Voznesensky, R Schaefer, ...
Clinical cancer research 21 (6), 1273-1280, 2015
Các cơ quan ủy nhiệm: US National Institutes of Health
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
KL Morel, AV Sheahan, DL Burkhart, SC Baca, N Boufaied, Y Liu, X Qiu, ...
Nature cancer 2 (4), 444-456, 2021
Các cơ quan ủy nhiệm: US National Institutes of Health, Fonds de recherche du Québec - Santé
SOX9 drives WNT pathway activation in prostate cancer
F Ma, H Ye, HH He, SJ Gerrin, S Chen, BA Tanenbaum, C Cai, ...
The Journal of clinical investigation 126 (5), 1745-1758, 2016
Các cơ quan ủy nhiệm: US National Institutes of Health
Cabozantinib eradicates advanced murine prostate cancer by activating antitumor innate immunity
A Patnaik, KD Swanson, E Csizmadia, A Solanki, N Landon-Brace, ...
Cancer Discovery 7 (7), 750-765, 2017
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health
A multi-resolution model for histopathology image classification and localization with multiple instance learning
J Li, W Li, A Sisk, H Ye, WD Wallace, W Speier, CW Arnold
Computers in biology and medicine 131, 104253, 2021
Các cơ quan ủy nhiệm: US National Institutes of Health
Evaluation of intense androgen deprivation before prostatectomy: a randomized phase II trial of enzalutamide and leuprolide with or without abiraterone
RR McKay, H Ye, W Xie, R Lis, C Calagua, Z Zhang, QD Trinh, SL Chang, ...
Journal of Clinical Oncology 37 (11), 923-931, 2019
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health
Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma
TL Lotan, H Ye, J Melamed, XR Wu, IM Shih, JI Epstein
The American journal of surgical pathology 33 (7), 1037-1041, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Clonal progression of prostate cancers from Gleason grade 3 to grade 4
AG Sowalsky, H Ye, GJ Bubley, SP Balk
Cancer research 73 (3), 1050-1055, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Decrease in stromal androgen receptor associates with androgen‐independent disease and promotes prostate cancer cell proliferation and invasion
Y Li, CX Li, H Ye, F Chen, J Melamed, Y Peng, J Liu, Z Wang, HC Tsou, ...
Journal of cellular and molecular medicine 12 (6b), 2790-2798, 2008
Các cơ quan ủy nhiệm: US National Institutes of Health
Low abundance of circulating tumor DNA in localized prostate cancer
ST Hennigan, SY Trostel, NT Terrigino, OS Voznesensky, RJ Schaefer, ...
JCO precision oncology 3, 1-13, 2019
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health
Expression of PD-L1 in hormone-naïve and treated prostate cancer patients receiving neoadjuvant abiraterone acetate plus prednisone and leuprolide
C Calagua, J Russo, Y Sun, R Schaefer, R Lis, Z Zhang, K Mahoney, ...
Clinical Cancer Research 23 (22), 6812-6822, 2017
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health
Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas
J Zavadil, H Ye, Z Liu, JJ Wu, P Lee, E Hernando, P Soteropoulos, ...
PloS one 5 (8), e12362, 2010
Các cơ quan ủy nhiệm: US National Institutes of Health
Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy
S Wilkinson, H Ye, F Karzai, SA Harmon, NT Terrigino, DJ VanderWeele, ...
European urology 80 (6), 746-757, 2021
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health
Neoadjuvant-intensive androgen deprivation therapy selects for prostate tumor foci with diverse subclonal oncogenic alterations
AG Sowalsky, H Ye, M Bhasin, EM Van Allen, M Loda, RT Lis, ...
Cancer research 78 (16), 4716-4730, 2018
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health
Results of a randomized phase II trial of intense androgen deprivation therapy prior to radical prostatectomy in men with high-risk localized prostate cancer
RR McKay, W Xie, H Ye, FM Fennessy, Z Zhang, R Lis, C Calagua, ...
The Journal of urology 206 (1), 80-87, 2021
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health
Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer
JW Russo, C Gao, SS Bhasin, OS Voznesensky, C Calagua, S Arai, ...
Cancer research 78 (22), 6354-6362, 2018
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health
ErbB2 signaling increases androgen receptor expression in abiraterone-resistant prostate cancer
S Gao, H Ye, S Gerrin, H Wang, A Sharma, S Chen, A Patnaik, ...
Clinical Cancer Research 22 (14), 3672-3682, 2016
Các cơ quan ủy nhiệm: US National Institutes of Health
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ